Liberty 2: Efficacy and safety study of Relugolix in women with heavy menstrual bleeding associated with uterine fibroids.
Sponsor: Myovant Sciences GmbH.
Investigador principal.
Spirit 1: Efficacy and safety sutdy of Relugolix in women with endometriosis – associated pain.
Sponsor: Myovant Sciences GmbH.
Investigador principal.
Evaluation of safety and efficancy of Proellex in the treatment of pre-menopausal women with confirmed, symptomatic endometriosis.
Sponsor: Repros Therapeutics Inc.
Investigador principal.
Global Phase 3 study to evaluate the safety and efficacy of Elagolix in subjects with moderate to severe endometriosis – associated pain.
Sponsor: AbbVie.
Investigdaro principal.
Study of contraceptive efficacy and safety of a NOMAC-E2 combined oral contracpetive.
Sponsor: Merck Sharp & Dohme Corp.
Investigador principal.
Fase III – rFSH “Filled by Mass”.
Sponsor: Serono Inc.
Sub-investigador.